Results 61 to 70 of about 28,228 (226)

Mechanisms of diabetic cardiomyopathy: Focus on inflammation

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2326-2338, May 2025.
Abstract Purpose of Review Type 2 diabetes (T2D) significantly increases the risk of heart failure (HF), either through the progression of coronary artery disease (CAD) or through direct myocardial alterations, termed diabetic cardiomyopathy. This review examines key pathophysiological mechanisms underlying diabetic cardiomyopathy, focusing on the role
Myriam Bellemare   +5 more
wiley   +1 more source

The effects of single and combined application of ramipril and losartan on renal structure and function in hypertensive rats

open access: yesClinical and Experimental Hypertension, 2018
The objective of the present study was to investigate the effects of single and combined administration of ramipril and losartan on renal structure and function in spontaneously hypertensive rats (SHRs). Thirty-two 9-week-old SHRs and eight Wistar-Kyoto (
Lin Yun   +7 more
doaj   +1 more source

Acquired Genotype‐Positive Long QT Syndrome After Pediatric Heart Transplantation

open access: yesPediatric Transplantation, Volume 29, Issue 3, May 2025.
ABSTRACT Background Congenital long QT syndrome (LQTS) is rare but significant, as it carries a risk for ventricular arrhythmias and sudden cardiac death. Its diagnosis can be made clinically by serial ECGs, ambulatory ECG monitoring, and exercise stress testing; however, genetic testing is confirmatory in the majority of cases.
Nicholas V. Barresi   +3 more
wiley   +1 more source

Hydrocephalus and Cerebral Small Vessel Disease in an Adult With Meningococcal Meningitis and Dilated Cardiomyopathy: A Fatal Outcome

open access: yesClinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Meningococcal meningitis can lead to serious neurological complications such as hydrocephalus directly and contribute to cerebral small vessel disease indirectly, especially in patients with pre‐existing conditions like dilated cardiomyopathy.
Yousif Mohamed   +3 more
wiley   +1 more source

Dapsone‐Induced Heinz Body Hemolytic Anemia: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Patients who develop acute anemia, without evidence of blood loss, should have a hemolysis workup including a medication review in case this could be contributing. In our patient's case, workup was significant for Heinz body hemolytic anemia due to home dapsone. Patient's anemia ultimately resolved with drug cessation.
Tyler Edwards   +2 more
wiley   +1 more source

Chronic Viral Infections and Al Amyloidosis: An Uncommon Association

open access: yesClinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT AL‐amyloidosis is caused by deposition of pathological insoluble proteins in organs and tissues. HIV infection is a multi‐system disorder causing chronic inflammation. We report a case of AL‐amyloidosis associated with HIV suggesting that HIV‐associated immune dysregulation might be critical for pathogenesis of plasma cells dyscrasias and then
Alberto Palladini   +7 more
wiley   +1 more source

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2010
Elizabeth Ripley, Ari HirschDivision of Nephrology, Virginia Commonwealth University, Richmond, Virginia, USAAbstract: Losartan, the first AT1 receptor blocker (ARB), was FDA approved 15 years ago.During those years, researchers and clinicians have ...
Elizabeth Ripley, Ari Hirsch
doaj  

Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension

open access: yesКардиоваскулярная терапия и профилактика, 2011
Aim. To assess the potential of the angiotensin II receptor antagonist losartan for the correction of hyperuricemia (HU) in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods.
S. V. Nedogoda   +3 more
doaj   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy